Items where authors include "McLornan, D.P."

Article

Passweg, J.R. orcid.org/0000-0001-7092-3351, Baldomero, H. orcid.org/0000-0002-6554-483X, Atlija, M. et al. (18 more authors) (2025) The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT. Bone Marrow Transplantation. pp. 1-10. ISSN 0268-3369

Passweg, J.R. orcid.org/0000-0001-7092-3351, Baldomero, H. orcid.org/0000-0002-6554-483X, Alexander, T. orcid.org/0000-0003-1193-0097 et al. (12 more authors) (2025) Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT. Bone Marrow Transplantation (60). 2. pp. 227-236. ISSN 0268-3369

Garderet, L. orcid.org/0000-0002-6138-8112, Gras, L., Koster, L. et al. (43 more authors) (2024) Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: a study of the worldwide network for blood and marrow transplantation (WBMT). American Journal of Hematology, 99 (11). pp. 2084-2095. ISSN 0361-8609

Atsuta, Y., Baldomero, H., Neumann, D. et al. (44 more authors) (2024) Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors. Haematologica, 109 (10). ISSN 0390-6078

Scheid, C. orcid.org/0009-0007-6539-226X, Eikema, D.-J., van Gelder, M. orcid.org/0000-0001-8698-4351 et al. (27 more authors) (2024) Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood, 144 (4). pp. 445-456. ISSN 0006-4971

Robin, M. orcid.org/0000-0003-1388-9876, Iacobelli, S., Koster, L. et al. (22 more authors) (2024) Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 59 (7). pp. 928-935. ISSN 0268-3369

Passweg, J.R. orcid.org/0000-0001-7092-3351, Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2024) Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone Marrow Transplantation, 59 (6). pp. 803-812. ISSN 0268-3369

Baldomero, H., Neumann, D., Hamad, N. et al. (35 more authors) (2024) The role of registries in hematological disorders. Best Practice & Research Clinical Haematology, 37 (2). 101556.

Gurnari, C. orcid.org/0000-0001-6829-5544, Koster, L., Baaij, L.G.A. et al. (30 more authors) (2024) Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood Advances, 8 (6). pp. 1444-1448. ISSN 2473-9529

Passweg, J.R., Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT activity survey. Bone Marrow Transplantation, 58 (6). pp. 647-658. ISSN 0268-3369

Yakoub-Agha, I. orcid.org/0000-0003-4524-8782, Greco, R. orcid.org/0000-0002-6117-5328, Onida, F. et al. (14 more authors) (2023) Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation, 58 (6). pp. 696-700. ISSN 0268-3369

Waszczuk-Gajda, A., Gras, L., de Wreede, L.C. orcid.org/0000-0002-7667-9369 et al. (22 more authors) (2023) Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—the DIADEM study from the chronic malignancies working party of the EBMT. Bone Marrow Transplantation, 58 (4). pp. 424-429. ISSN 0268-3369

Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609

Proceedings Paper

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 708-710.

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic hematopoietic cell transplantation for Vexas syndrome: results of a multicenter study from the chronic malignancies and autoimmune disease working parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 708.

Mizuno, S., Gras, L., Baaij, L. et al. (42 more authors) (2023) Impact of age on outcome in newly diagnosed multiple myeloma patients undergoing upfront autologous hematopoietic cell transplantation from the worldwide network for blood and marrow transplantation global study. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 785.

Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) Long term outcomes and renal response following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Cmwp of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 3403.

Robin, M., Iacobelli, S., Passweg, J.R. et al. (22 more authors) (2023) Treosulfan compared to Busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the chronic malignancies working party of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 473.